Skip to main content
. 2016 Jul 13;7(34):55395–55408. doi: 10.18632/oncotarget.10577

Table 1. JMML patients characteristics.

Sample Gender Age (years) Karyotype Mutation
JMML 1 F 1.3 ND CBL
JMML 2 F 6.2 normal CBL
JMML 3 ND 0.6 normal CBL
JMML 4 M 0.9 ND KRAS
JMML 5 M 0.9 normal KRAS
JMML 6 M 0.7 normal KRAS
JMML 7 F 1.6 normal KRAS
JMML 8 F 1.5 ND KRAS
JMML 9 M 1.5 normal KRAS
JMML 10 M 2.1 normal KRAS
JMML 11 M 0.5 +mar KRAS
JMML 12 M 0.1 normal KRAS
JMML 13 M 0.5 −7, +mar KRAS
JMML 14 M 0.3 −7, +mar KRAS
JMML 15 M 0.9 normal NRAS
JMML 16 F 1.7 normal NRAS
JMML 17 F 1.7 normal NRAS
JMML 18 M 1.0 normal NRAS
JMML 19 M 1.1 normal NRAS
JMML 20 ND 1.2 normal NRAS
JMML 21 M 0.3 normal NRAS
JMML 22 M 5.4 normal NRAS
JMML 23 M 2.6 normal NRAS
JMML 24 M 0.5 normal NRAS
JMML 25 M 1.5 normal PTPN11
JMML 26 F 5.7 −7, +21,+mar PTPN11
JMML 27 M ND ND PTPN11
JMML 28 F 2.4 normal PTPN11
JMML 29 F 0.2 normal PTPN11
JMML 30 F 3.7 ND PTPN11
JMML 31 F 0.4 normal PTPN11
JMML 32 M 6.2 normal PTPN11
JMML 33 M 3.7 normal PTPN11
JMML 34 F 2.0 ND PTPN11
JMML 35 M ND ND PTPN11
JMML 36 M ND ND PTPN11
JMML 37 F 0.9 −7 UNKN
JMML 38 M 9.1 −7 UNKN
JMML 39 M ND normal UNKN
JMML 40 M 2.6 normal UNKN

ND= Not Determined; +mar= Marker Chromosome; +21= Chromosome 21 trisomy; −7= Chromosome 7 monosomy; normal= Normal Karyotype